Medtronic reports positive EV ICD pivotal trial results
The trial confirms the safety of the EV-ICD system, with high ATP success rates and effective defibrillation.
03 September 2024
03 September 2024
The trial confirms the safety of the EV-ICD system, with high ATP success rates and effective defibrillation.
The ruling will impact how the European Commission handles investigations going forward, in a major blow for the body.
Elixir’s DynamX Bioadaptor could possess longer-term plateauing of adverse events compared to Medtronic’s marketed drug-eluting stent.
The algorithms bolster the ability of Aidoc’s aiOS platform to alert radiologists to suspected pathologies found in medical images.
The MosaiQ AiPlex CD assay offers a novel approach to celiac disease testing by incorporating autoantibodies.
The software products are designed for accelerated and reduced isotope scans, as well as automated lesion detection.
The $1.1m grant will fund the enrolment of an additional four participants to be implanted with Onward’s ARC-BCI system.
The new method for cancer detection uses light analysis of dehydrated blood crystals.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.